Dr Angharad Watson

Ager, E., Watson, H. A., Wehenkel, S. C. and Mohammed, R. N. 2016. Homing to solid cancers: a vascular checkpoint in adoptive cell therapy using CAR T-cells. Biochemical Society Transactions 44(2), pp. 377-385. (10.1042/BST20150254)
Watson, H. A., Wehenkel, S., Matthews, J. and Ager, E. 2016. SHP-1: the next checkpoint target for cancer immunotherapy?. Biochemical Society Transactions 44(2), pp. 356-362. (10.1042/BST20150251)
Mohammed, R. N., Watson, H. A., Vigar, M., Ohme, J., Thomson, A., Humphreys, I. R. and Ager, A. 2016. L-selectin is essential for delivery of activated CD8+ T cells to virus-infected organs for protective immunity. Cell Reports 14(4), pp. 760-771. (10.1016/j.celrep.2015.12.090)

Watson, H. A. et al. 2019. L-selectin enhanced T cells improve the efficacy of cancer immunotherapy. Frontiers in Immunology 10, article number: 1321. (10.3389/fimmu.2019.01321)
Ager, E., Watson, H. A., Wehenkel, S. C. and Mohammed, R. N. 2016. Homing to solid cancers: a vascular checkpoint in adoptive cell therapy using CAR T-cells. Biochemical Society Transactions 44(2), pp. 377-385. (10.1042/BST20150254)
Watson, H. A., Wehenkel, S., Matthews, J. and Ager, E. 2016. SHP-1: the next checkpoint target for cancer immunotherapy?. Biochemical Society Transactions 44(2), pp. 356-362. (10.1042/BST20150251)
Mohammed, R. N., Watson, H. A., Vigar, M., Ohme, J., Thomson, A., Humphreys, I. R. and Ager, A. 2016. L-selectin is essential for delivery of activated CD8+ T cells to virus-infected organs for protective immunity. Cell Reports 14(4), pp. 760-771. (10.1016/j.celrep.2015.12.090)
Spary, L. K. et al. 2014. Enhancement of T cell responses as a result of synergy between lower doses of radiation and T cell stimulation. The Journal of Immunology 192(7), pp. 3101-3110. (10.4049/jimmunol.1302736)

Publication